Quan Lili, Uyeda Akiko, Muramatsu Rieko
Department of Molecular Pharmacology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
Inflamm Regen. 2022 Mar 2;42(1):7. doi: 10.1186/s41232-022-00193-y.
Glial cells play crucial roles in brain homeostasis and pathogenesis of central nervous system (CNS) injuries and diseases. However, the roles of these cells and the molecular mechanisms toward regeneration in the CNS have not been fully understood, especially the capacity of them toward demyelinating diseases. Therefore, there are still very limited therapeutic strategies to restore the function of adult CNS in diseases such as multiple sclerosis (MS). Remyelination, a spontaneous regeneration process in the CNS, requires the involvement of multiple cellular and extracellular components. Promoting remyelination by therapeutic interventions is a promising novel approach to restore the CNS function. Herein, we review the role of glial cells in CNS diseases and injuries. Particularly, we discuss the roles of glia and their functional interactions and regulatory mechanisms in remyelination, as well as the current therapeutic strategies for MS.
神经胶质细胞在脑内环境稳定以及中枢神经系统(CNS)损伤和疾病的发病机制中发挥着关键作用。然而,这些细胞的作用以及中枢神经系统再生的分子机制尚未完全明确,尤其是它们在脱髓鞘疾病中的作用。因此,在诸如多发性硬化症(MS)等疾病中,恢复成体中枢神经系统功能的治疗策略仍然非常有限。髓鞘再生是中枢神经系统中的一个自发再生过程,需要多种细胞和细胞外成分的参与。通过治疗干预促进髓鞘再生是恢复中枢神经系统功能的一种有前景的新方法。在此,我们综述神经胶质细胞在中枢神经系统疾病和损伤中的作用。特别地,我们讨论了神经胶质细胞在髓鞘再生中的作用及其功能相互作用和调节机制,以及目前针对多发性硬化症的治疗策略。